Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Revenue projections:

Revenue projections for ABBOTINDIA
Revenue projections for ABBOTINDIA

With Abbott India Limited's revenues forecasted to be lower than last year's, investors are expected to be cautious. A decline in revenue typically harms the company's bottom line, reducing profitability and making investors less confident about the company's ability to sustain its financial health.

Financial Ratios:

currentRatio 0.000000
forwardPE 32.471577
debtToEquity 4.549000
earningsGrowth 0.042000
revenueGrowth 0.068000
grossMargins 0.464090
operatingMargins 0.257940
trailingEps 716.310000
forwardEps 817.022200

ABBOTINDIA's positive gross and operating margins suggest strong profitability. These margins reflect effective cost management and revenue generation, indicating that the company is efficiently managing its operations and maintaining financial health.
ABBOTINDIA's forward EPS being higher than its trailing EPS suggests that the company is expected to generate stronger profits this year. This points to improving financial performance, with ABBOTINDIA anticipated to deliver better earnings than it did in the prior year.

Price projections:

Price projections for ABBOTINDIA
Price projections for ABBOTINDIA

The price of ABBOTINDIA has regularly been close to the lower end of projections, suggesting that it might be struggling to meet market expectations. This trend raises questions about the company's future performance.

Recommendation changes over time:

Recommendations trend for ABBOTINDIA
Recommendations trend for ABBOTINDIA


Analysts have shown a buy bias for ABBOTINDIA, signaling it as a strong investment choice. This positive outlook could motivate investors to allocate funds to ABBOTINDIA, seeing it as a reliable and potentially profitable option, especially in an environment where the stock market is highly scrutinized.